Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Glenmark Pharma

    Tag: glenmark pharma

    You Searched For "Glenmark Pharma"
    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    Medical Dialogues Bureau7 Nov 2019 4:20 PM IST
    Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Medical Dialogues Bureau8 May 2019 9:15 AM IST
    Yasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a...
    Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

    Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

    Farhat Nasim25 April 2019 10:50 AM IST
    The approved product Estradiol Vaginal Inserts USP, 10 mcg is a generic version of Novo Nordisk Inc's VAGIFEM. New Delhi: Glenmark Pharmaceuticals has...
    Glenmark inks pact with private equity firm True North

    Glenmark inks pact with private equity firm True North

    Ruby Khatun Khatun15 Aug 2018 10:30 AM IST
    New Delhi: Glenmark Pharmaceuticals said it has entered into a collaboration with private equity firm True North for its orthopaedic and pain...
    Glenmark completes phase 3 study for nasal spray

    Glenmark completes phase 3 study for nasal spray

    Ruby Khatun Khatun15 Dec 2017 10:15 AM IST
    New Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
    Glenmark gets USFDA nod for contraceptive tablets

    Glenmark gets USFDA nod for contraceptive tablets

    Ruby Khatun Khatun22 Nov 2017 10:30 AM IST
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Loestrin tablets used to...
    Glenmark Pharmaceuticals launches nicotine gum Kwitz

    Glenmark Pharmaceuticals launches nicotine gum Kwitz

    Ruby Khatun Khatun18 Nov 2017 10:30 AM IST
    New Delhi: Glenmark Pharmaceuticals said it has launched nicotine replacement therapy product Kwitz that helps smokers quit smoking.Kwitz nicotine gum...
    Glenmark expects generics to drive growth over next 3 yrs

    Glenmark expects generics to drive growth over next 3 yrs

    Ruby Khatun Khatun25 Sept 2017 10:37 AM IST
    Mumbai: Pharma firm Glenmark Pharmaceuticals has said its pipeline of specialty and innovative products over the next three to four years is expected...
    Glenmark gets USFDA nod for chest pain tablets

    Glenmark gets USFDA nod for chest pain tablets

    Ruby Khatun Khatun22 Sept 2017 10:47 AM IST
    New Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
    Glenmark looks to file up to 25 product applications annually

    Glenmark looks to file up to 25 product applications annually

    Ruby Khatun Khatun19 Sept 2017 10:19 AM IST
    New Delhi: Glenmark Pharmaceuticals plans to file close to 25 product applications annually over the next five years, the company's chairman has...
    Glenmark gets USFDA approval for Rythmol SR generic

    Glenmark gets USFDA approval for Rythmol SR generic

    Ruby Khatun Khatun13 Sept 2017 2:08 PM IST
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok